AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS) ...
Roche has been trumpeting the rapid uptake of its new eye disease drug Vabysmo as it takes on Regeneron and Bayer's mighty Eylea in the US – and could soon start making inroads against its rival in ...
The availability of complete genome sequences has coincided with the development of technologies to monitor mRNA expression across the genome 1,2,3,4. These expression data provide a global view of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results